JP2013502451A5 - - Google Patents

Download PDF

Info

Publication number
JP2013502451A5
JP2013502451A5 JP2012526125A JP2012526125A JP2013502451A5 JP 2013502451 A5 JP2013502451 A5 JP 2013502451A5 JP 2012526125 A JP2012526125 A JP 2012526125A JP 2012526125 A JP2012526125 A JP 2012526125A JP 2013502451 A5 JP2013502451 A5 JP 2013502451A5
Authority
JP
Japan
Prior art keywords
compound according
motomeko
alkyl
independently selected
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012526125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013502451A (ja
JP5828839B2 (ja
Filing date
Publication date
Priority claimed from GBGB0914767.9A external-priority patent/GB0914767D0/en
Application filed filed Critical
Publication of JP2013502451A publication Critical patent/JP2013502451A/ja
Publication of JP2013502451A5 publication Critical patent/JP2013502451A5/ja
Application granted granted Critical
Publication of JP5828839B2 publication Critical patent/JP5828839B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012526125A 2009-08-24 2010-08-23 アロマターゼ阻害剤 Expired - Fee Related JP5828839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0914767.9A GB0914767D0 (en) 2009-08-24 2009-08-24 Compound
GB0914767.9 2009-08-24
PCT/GB2010/051391 WO2011023989A1 (en) 2009-08-24 2010-08-23 Aromatase inhibitor

Publications (3)

Publication Number Publication Date
JP2013502451A JP2013502451A (ja) 2013-01-24
JP2013502451A5 true JP2013502451A5 (https=) 2013-09-05
JP5828839B2 JP5828839B2 (ja) 2015-12-09

Family

ID=41171838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012526125A Expired - Fee Related JP5828839B2 (ja) 2009-08-24 2010-08-23 アロマターゼ阻害剤

Country Status (7)

Country Link
US (1) US8846737B2 (https=)
EP (1) EP2470512B1 (https=)
JP (1) JP5828839B2 (https=)
CN (1) CN102596919B (https=)
GB (1) GB0914767D0 (https=)
RU (1) RU2572244C2 (https=)
WO (1) WO2011023989A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100609A1 (en) * 2013-12-31 2015-07-09 Beaufour Ipsen Tianjin Pharmaceutical Co., Ltd New substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase
DE102017116299A1 (de) 2017-07-19 2019-01-24 Huf Hülsbeck & Fürst Gmbh & Co. Kg Verfahren zum Zuordnen einer Reifendrucküberwachungseinheit zu einer Radposition eines Fahrzeugs
MX2020003242A (es) 2017-09-22 2020-09-18 Jubilant Epipad LLC Compuestos heterociclicos como inhibidores de pad.
AU2018352142B2 (en) 2017-10-18 2022-08-25 Jubilant Epipad LLC Imidazo-pyridine compounds as PAD inhibitors
KR20200085836A (ko) 2017-11-06 2020-07-15 주빌런트 프로델 엘엘씨 Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
BR112020010322A2 (pt) 2017-11-24 2020-11-17 Jubilant Episcribe Llc composto da fórmula i; composto da fórmula ia; composto da fórmula ib; processo de preparação de compostos da fórmula i; composição farmacêutica; método para o tratamento e/ou prevenção de várias doenças; uso dos compostos; método para o tratamento de câncer; e método para o tratamento e/ou prevenção de uma afecção mediada por prmt5 ou um distúrbio proliferativo ou câncer
LT3728207T (lt) 2017-12-21 2023-05-25 Ribon Therapeutics Inc. Chinazolinonai kaip parp14 inhibitoriai
SG11202008950PA (en) 2018-03-13 2020-10-29 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
PL239999B1 (pl) * 2018-06-18 2022-02-07 Politechnika Gdanska A midosiarczanowe pochodne 4-(1-fenylo-1H-[1,2,3]triazol- -4-ylo)-fenolu, ich zastosowanie medyczne i diagnostyczne, oraz sposób otrzymywania amidosiarczanowych pochodnych 4-(1-fenylo- 1H-[1,2,3]triazol-4-ylo)-fenolu
CN113387894B (zh) * 2021-06-22 2023-02-24 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 1-n-苯乙腈基氨基-三氮唑和嘧啶衍生物及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
GB9003939D0 (en) 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
TW210334B (https=) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9118478D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
TW225526B (https=) 1991-09-02 1994-06-21 Yamanouchi Pharma Co Ltd
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
GB9422777D0 (en) 1994-11-11 1995-01-04 Imperial College Assay
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
DE69729007T2 (de) 1996-08-07 2005-04-07 Darwin Discovery Ltd., Slough Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung
ATE424410T1 (de) 1996-08-30 2009-03-15 Human Genome Sciences Inc Interleukin-19.
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
KR100517452B1 (ko) 1996-09-25 2007-03-15 히사미쓰 메디카루 가부시키가이샤 치환 비닐피리딘 유도체 및 이를 함유하는 의약
US6297239B1 (en) 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US6585954B1 (en) 1998-03-26 2003-07-01 Kyowa Hakko Kogyo Co., Ltd. Method for searching steroid sulfatase inhibitors
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
US20020019527A1 (en) 2000-04-27 2002-02-14 Wei-Bo Wang Substituted phenyl farnesyltransferase inhibitors
CA2464770C (en) 2001-11-21 2011-08-16 Sterix Limited Compound
EP1431292A1 (en) * 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors
EP1544195A1 (en) 2003-12-15 2005-06-22 Laboratoire Theramex 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
BRPI0417407A (pt) * 2003-12-15 2007-04-03 Theramex derivados de 1-n-fenil-amino-1h-imidazol e composições farmacêuticas contendo estes
GB0411562D0 (en) 2004-05-24 2004-06-23 Sterix Ltd Compound
EP2037884A2 (en) * 2006-06-22 2009-03-25 Novartis AG Sustained release formulations of aromatase inhibitors

Similar Documents

Publication Publication Date Title
JP2013502451A5 (https=)
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
JP2014520898A5 (https=)
JP2012523457A5 (https=)
JP2013538802A5 (https=)
JP2014518882A5 (https=)
IL283592B2 (en) Inhibitors of apol1 and methods of using same
JP2006528205A5 (https=)
RU2017121906A (ru) Конъюгаты цистеамина и жирной кислоты и их применение в качестве активаторов аутофагии
JP2011511095A5 (https=)
JP2017504576A5 (https=)
RU2013156074A (ru) Диазакарбазолы и способы применения
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2017506250A5 (https=)
HRP20170500T1 (hr) Heterociklički modulatori sinteze lipida
ME02754B (me) Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
JP2009515872A5 (https=)
RU2012144317A (ru) Противоинфекционные соединения
JP2011137006A5 (https=)
JP2017531041A5 (https=)
RU2012111119A (ru) Ингибиторы ароматазы
JP2013508288A5 (https=)
JP2005511545A5 (https=)
JP2011506588A5 (https=)
JP2020500182A5 (https=)